Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
Clinical trial NCT03005782 · COMPLETED
Trial details
- NCT number
- NCT03005782
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-07
- Primary completion
- 2024-04-02
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.